Previous Article | Next Article 
Journal of Virology, December 2000, p. 11173-11180, Vol. 74, No. 23
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
DNA Vaccines Encoding Interleukin-8 and RANTES
Enhance Antigen-Specific Th1-Type CD4+ T-Cell-Mediated
Protective Immunity against Herpes Simplex Virus Type 2 In
Vivo
Jeong-Im
Sin,1
Jong J.
Kim,1
Catherine
Pachuk,2
C.
Satishchandran,2 and
David B.
Weiner1,*
Department of Pathology and Laboratory
Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
19104,1 and WLP, Malvern, Pennsylvania
193552
Received 3 January 2000/Accepted 8 September 2000
Chemokines are inflammatory molecules that act primarily as
chemoattractants and as activators of leukocytes. Their role in antigen-specific immune responses is of importance, but their role in
disease protection is unknown. Recently it has been suggested that
chemokines modulate immunity along more classical Th1 and Th2
phenotypes. However, no data currently exist in an infectious challenge
model system. We analyzed the modulatory effects of selected chemokines
(interleukin-8 [IL-8], gamma interferon-inducible protein 10 [IP-10], RANTES, monocyte chemotactic protein 1 [MCP-1], and
macrophage inflammatory protein 1
[MIP-1
]) on immune phenotype and protection against lethal challenge with herpes simplex virus type
2 (HSV-2). We observed that coinjection with IL-8 and RANTES plasmid
DNAs dramatically enhanced antigen-specific Th1 type cellular immune
responses and protection from lethal HSV-2 challenge. This enhanced
protection appears to be mediated by CD4+ T cells, as
determined by in vitro and in vivo T-cell subset deletion. Thus, IL-8
and RANTES cDNAs used as DNA vaccine adjuvants drive antigen-specific
Th1 type CD4+ T-cell responses, which result in reduced
HSV-2-derived morbidity, as well as reduced mortality. However,
coinjection with DNAs expressing MCP-1, IP-10, and MIP-1
increased
mortality in the challenged mice. Chemokine DNA coinjection also
modulated its own production as well as the production of cytokines.
These studies demonstrate that chemokines can dominate and drive
immune responses with defined phenotypes, playing an important role in
the generation of protective antigen-specific immunity.
*
Corresponding author. Mailing address: Department of
Pathology and Laboratory Medicine, University of Pennsylvania, 505 Stellar-Chance Lab, 422 Curie Dr., Philadelphia, PA 19104. Phone: (215)
662-2352. Fax: (215) 573-9436. E-mail:
dbweiner{at}mail.med.upenn.edu.
Journal of Virology, December 2000, p. 11173-11180, Vol. 74, No. 23
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Jamali, A., Mahdavi, M., Hassan, Z. M., Sabahi, F., Farsani, M. J., Bamdad, T., Soleimanjahi, H., Motazakker, M., Shahabi, S.
(2009). A novel adjuvant, the general opioid antagonist naloxone, elicits a robust cellular immune response for a DNA vaccine. Int Immunol
21: 217-225
[Abstract]
[Full Text]
-
Thapa, M., Welner, R. S., Pelayo, R., Carr, D. J. J.
(2008). CXCL9 and CXCL10 Expression Are Critical for Control of Genital Herpes Simplex Virus Type 2 Infection through Mobilization of HSV-Specific CTL and NK Cells to the Nervous System. J. Immunol.
180: 1098-1106
[Abstract]
[Full Text]
-
Thapa, M., Kuziel, W. A., Carr, D. J. J.
(2007). Susceptibility of CCR5-Deficient Mice to Genital Herpes Simplex Virus Type 2 Is Linked to NK Cell Mobilization. J. Virol.
81: 3704-3713
[Abstract]
[Full Text]
-
Herbst-Kralovetz, M. M., Pyles, R. B.
(2006). Quantification of Poly(I:C)-Mediated Protection against Genital Herpes Simplex Virus Type 2 Infection.. J. Virol.
80: 9988-9997
[Abstract]
[Full Text]
-
Baba, T., Ishizu, A., Iwasaki, S., Suzuki, A., Tomaru, U., Ikeda, H., Yoshiki, T., Kasahara, M.
(2006). CD4+/CD8+ macrophages infiltrating at inflammatory sites: a population of monocytes/macrophages with a cytotoxic phenotype. Blood
107: 2004-2012
[Abstract]
[Full Text]
-
Liu, J., Guan, X., Ma, X.
(2005). Interferon Regulatory Factor 1 Is an Essential and Direct Transcriptional Activator for Interferon {gamma}-induced RANTES/CCl5 Expression in Macrophages. J. Biol. Chem.
280: 24347-24355
[Abstract]
[Full Text]
-
Mogensen, T. H., Melchjorsen, J., Malmgaard, L., Casola, A., Paludan, S. R.
(2004). Suppression of Proinflammatory Cytokine Expression by Herpes Simplex Virus Type 1. J. Virol.
78: 5883-5890
[Abstract]
[Full Text]
-
Aurelian, L.
(2004). Herpes Simplex Virus Type 2 Vaccines: New Ground for Optimism?. CVI
11: 437-445
[Abstract]
[Full Text]
-
Melchjorsen, J., Paludan, S. R.
(2003). Induction of RANTES/CCL5 by herpes simplex virus is regulated by nuclear factor {kappa}B and interferon regulatory factor 3. J. Gen. Virol.
84: 2491-2495
[Abstract]
[Full Text]
-
Melchjorsen, J., Sorensen, L. N., Paludan, S. R.
(2003). Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function. J. Leukoc. Biol.
74: 331-343
[Abstract]
[Full Text]
-
Kim, T.-Y., Myoung, H.-J., Kim, J.-H., Moon, I.-S., Kim, T.-G., Ahn, W.-S., Sin, J.-I.
(2002). Both E7 and CpG-Oligodeoxynucleotide Are Required for Protective Immunity against Challenge with Human Papillomavirus 16 (E6/E7) Immortalized Tumor Cells: Involvement of CD4+ and CD8+ T Cells in Protection. Cancer Res.
62: 7234-7240
[Abstract]
[Full Text]
-
Melchjorsen, J., Pedersen, F. S., Mogensen, S. C., Paludan, S. R.
(2002). Herpes Simplex Virus Selectively Induces Expression of the CC Chemokine RANTES/CCL5 in Macrophages through a Mechanism Dependent on PKR and ICP0. J. Virol.
76: 2780-2788
[Abstract]
[Full Text]